Changes of laminin beta 2 chain expression in congenital muscular dystrophy

被引:32
|
作者
Cohn, RD [1 ]
Herrmann, R [1 ]
Wewer, UM [1 ]
Voit, T [1 ]
机构
[1] UNIV COPENHAGEN,INST MOL PATHOL,COPENHAGEN,DENMARK
关键词
congenital muscular dystrophy; laminin; extracellular matrix; Walker-Warburg syndrome; immunohistochemistry;
D O I
10.1016/S0960-8966(97)00072-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We studied the distribution of laminin beta 2 chain in the skeletal muscle basement membrane of 16 patients with congenital muscular dystrophy (CMD) by immunohistochemistry. A dramatic reduction in the laminin beta 2 staining was observed in four patients with classical merosin-negative CMD. A moderate reduction of laminin beta 2 labelling was observed in four patients with partial merosin deficiency and two patients with merosin-positive CMD. Two patients with merosin-positive CMD had no apparent changes in the expression of laminin beta 2. In three patients and one fetus diagnosed as Walker-Warburg syndrome (WWS) the laminin beta 2 pattern was similar to normal controls. We conclude that a primary deficiency in the laminin alpha 2 chain may lead to a vast or moderate reduction in the laminin beta 2 chain in the skeletal muscle membrane. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:373 / 378
页数:6
相关论文
共 50 条
  • [1] Laminin α2 (or M) chain abnormality in congenital muscular dystrophy
    Hayashi, YK
    Nonaka, I
    Arahata, K
    CONGENITAL MUSCULAR DYSTROPHIES, 1997, 13 : 259 - 265
  • [2] EXPRESSION OF LAMININ SUBUNITS IN CONGENITAL MUSCULAR-DYSTROPHY
    SEWRY, CA
    PHILPOT, J
    MAHONY, D
    WILSON, LA
    MUNTONI, F
    DUBOWITZ, V
    NEUROMUSCULAR DISORDERS, 1995, 5 (04) : 307 - 316
  • [3] Laminin α2 chain-deficient congenital muscular dystrophy -: Variable epitope expression in severe and mild cases
    Cohn, RD
    Herrmann, R
    Sorokin, L
    Wewer, UM
    Voit, T
    NEUROLOGY, 1998, 51 (01) : 94 - 100
  • [4] Congenital muscular dystrophy with primary partial laminin α2 chain deficiency:: Molecular study
    He, Y
    Jones, KJ
    Vignier, N
    Morgan, G
    Chevallay, M
    Barois, A
    Estournet-Mathiaud, B
    Hori, H
    Mizuta, T
    Tomé, FMS
    North, KN
    Guicheney, P
    NEUROLOGY, 2001, 57 (07) : 1319 - 1322
  • [5] Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-α2 deficient congenital muscular dystrophy;: is congenital muscular dystrophy a primary fibrotic disease?
    Taniguchi, M
    Kurahashi, H
    Noguchi, S
    Sese, J
    Okinaga, T
    Tsukahara, T
    Guicheney, P
    Ozono, K
    Nishino, I
    Morishita, S
    Toda, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 342 (02) : 489 - 502
  • [6] Do alterations in laminin beta 2 localisation indicate a role of laminin-4 in congenital muscular dystrophy?
    Jimenez-Mallebrera, C
    Feng, L
    Brown, SC
    Muntoni, F
    Sewry, CA
    NEUROMUSCULAR DISORDERS, 2003, 13 (7-8) : 656 - 656
  • [7] Laminin α1 chain reduces muscular dystrophy in laminin α2 chain deficient mice
    Gawlik, K
    Miyagoe-Suzuki, Y
    Ekblom, P
    Takeda, S
    Durbeej, M
    HUMAN MOLECULAR GENETICS, 2004, 13 (16) : 1775 - 1784
  • [8] Expression profiling of muscles from Fukuyama-type congenital muscular dystrophy and laminin-alpha2 deficient congenital muscular dystrophy; is congenital muscular dystrophy a primary fibrotic disease?
    Taniguchi, M.
    Kurahashi, H.
    Noguchi, S.
    Sese, J.
    Okinaga, T.
    Tsukahara, T.
    Guicheney, P.
    Ozono, K.
    Nishino, I.
    Morishita, S.
    Toda, T.
    NEUROMUSCULAR DISORDERS, 2006, 16 (9-10) : 683 - 684
  • [9] A novel laminin α2 isoform in severe laminin α2 deficient congenital muscular dystrophy
    Pegoraro, E
    Fanin, M
    Trevisan, CP
    Angelini, C
    Hoffman, EP
    NEUROLOGY, 2000, 55 (08) : 1128 - 1134
  • [10] Laminin-α2 Chain-Deficient Congenital Muscular Dystrophy: Pathophysiology and Development of Treatment
    Durbeej, Madeleine
    BASEMENT MEMBRANES, 2015, 76 : 31 - 60